(02) 9926 4726
SydneyVital.admin@sydney.edu.au

News and Event

Understanding and Overcoming Mechanisms of Drug Resistance in Tumours

CALL FOR EOI’S FOR PILLAR LEADERS

Sydney Vital is seeking 2 individuals to act as leaders for Pillar 3 – “Understanding and Overcoming Mechanisms of Drug Resistance in Tumours”. The Pillar’s aims are deliberately broad to allow scope to explore and exploit strengths within the partner organisations. The Pillar provides base funding of $15 k p.a. (which can be further leveraged) to support activities to bring Pillar members together to develop new programs of research, both basic science and clinical, and to expand networks and collaborations. Ideally, the Pillars would have outputs that impact on the T1, T2 and T3 domains of translational research as defined by the CINSW, or the Flagship Programs 1, 2, or 3 of Sydney Vital . The Pillar leaders would ideally be researchers who are currently developing their research portfolio and might be classified as early to mid-career researchers. A clinician and a basic/pre-clinical scientist is the preferred combination of Sydney Vital.
Closing date for EOI: Thursday, 30th April 2015. Read more: SYDNEY VITAL_Pillar Leads 3_EOI

Read more

Determining why and when early stage cancer recurs

CALL FOR EOI’S FOR PILLAR LEADERS

Sydney Vital_EoI_Pillar 2 Lead 2015_V01

Read more

Defining and Achieving State-of-the-Art Cancer Diagnosis and Treatment

CALL FOR EOI’S FOR PILLAR LEADERS

EoI - Pillar Lead 2015 V1 1

Read more

IMPLEMENTATION RESEARCH- FELLOWSHIP APPLICATION

SYDNEY VITAL calls for Research Fellowship APPLICATIONS: Applications are invited from suitable qualified researchers for a Research Fellowship under Sydney Vital Flagship Program in the area of Implementation of Supportive Care for Cancer Patients. Closing date for application: Friday, December 5th, 2014. Read more Implementation Research_Fellowship Application

Read more

Research Fellowship – Applications

SYDNEY VITAL calls for Research Fellowship APPLICATIONS:

Applications are invited from suitable qualified researchers for a Research Fellowship under Sydney Vital Flagship Program 1: Research Fellowship in the area of Preclinical modelling of new therapies for treatment-resistant cancers.

Closing date for application: Friday, November 28, 2014. Read more Research Fellowship _ Application

Read more

Research Scholar Awards

SYDNEY VITAL is pleased to offer Research Scholar Awards to the value of $15,000 each for one year to students working in the area of translational cancer research. These awards are to be used to support the student’s research and are to be spent at the discretion of the student and their supervisor(s). Closing date for application: Friday, 17th October 2014.
Read more Scholar Award-Guidelines 2014

Read more

Postgraduate Scholarship – Closed

microRNA Translational Research

Funding Body:
The Kolling Institute of Medical Research

Funding Source:
Sydney Medical School Foundation

Description:
The Kolling Institute of Medical Research is the principal centre of health and medical research affiliated with the Northern Sydney Local Health District. As a centre of research excellence the Kolling has a major role in research training through the Sydney Medical School (Northern Clinical School) of the University of Sydney.

The Cancer Genetics Adrenal Laboratory studies neoplasms of the adrenal cortex (adrenocortical tumours) and of the adrenal medulla (phaeochromocytomas). Overall the work focuses on discovering markers to assist with the early identification of malignancy, and finding genes which will lead to a greater understanding of the pathogenesis of adrenal tumours and thereby ultimately improving the clinical management of these patients and their families. Adrenocortical cancer (ACC) is an aggressive malignancy with limited treatment options. Recent studies have shown that a number of microRNAs are down-regulated in ACC, indicating their potential as a tumour suppressor gene and therapeutic target.

We are pleased to offer a PhD scholarship to a skilled and motivated PhD candidate to join our translational research team headed by Professor Stan Sidhu. We are seeking applications from outstanding medical science/biology graduates who are interested in pursuing a career in translation medical research, in particular cancer research. The role involves an interdisciplinary research project elucidating the mechanism of microRNA as a tumour suppressor gene and potential therapeutic target in ACC. This project will provide an opportunity to gain experience in cancer genetics, cell biology and cancer translational research.

The successful full-time candidates will be supervised by Dr Jing Ting Zhao and Professor Stan Sidhu and. The position is located in the Cancer Genetics Group of the Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonard, NSW, 2065.

Eligibility:
The successful candidate will have:

  • Bachelor of Medical Science/Biology with Class I Honours or equivalent
  • Demonstrated commitment to quality and detailed research experiments and analysis of results.
  • Strong communication skills and the ability to work as a part of team
  • Australian citizenship or permanent residency

Amount awarded:
$25,392 per annum (tax exempt), up to 3 years. The stipend rate is indexed annually on 1st January.

Application guide:
To submit an application for this position please email directly to Dr Jing Ting Zhao at jing.zhao@sydney.edu.au.

  • Applications should include a cover letter with a brief research statement addressing the above criteria, a current CV including names of two referees and a copy of your Academic Transcripts.
  • All enquiries are forwarded to Dr Jing Ting Zhao on the email above or (02) 9926 4769.

Students with an interest in cancer genetics, endocrinology and related fields of translational medicine are encouraged to apply.

Closing date:
10th October 2014

Read more